<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01025180</url>
  </required_header>
  <id_info>
    <org_study_id>PCT-F-2005-10</org_study_id>
    <nct_id>NCT01025180</nct_id>
  </id_info>
  <brief_title>Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection</brief_title>
  <acronym>Pro-SEPS</acronym>
  <official_title>Randomized Multicentre Prospective Study of Procalcitonin-guided Treatment on Antibiotic Use and Outcome in Severe Sepsis ICU Patients Without Obvious Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brahms France</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brahms France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A recent study has demonstrated that in low respiratory infections, a strategy using
      prescription of antibiotics based on the pro-calcitonin level allows decreasing recourse to
      antibiotics by 47% without prognostic modification.

      The aim is to evaluate the impact on antibiotics consumption of an algorithm using
      procalcitonin level in patients exhibiting severe sepsis symptomatology but without clearly
      identified hosted germs or infectious centre.

      This multicenter study is a randomized prospective open study involving 9 ICU departments in
      France, comparing two strategies on antibiotherapy treatment period one based on
      procalcitonin level(experimental group) the other on physician's appreciation(control group)

      140 adult patients should be included with a severe sepsis symptomatology, whose infectious
      etiology has not been proven. The main non-inclusion criterium is: the presence of a pathogen
      agent or infectious centre clearly identified.

      The primary outcome is the rate of patients undergoing antibiotic treatment at D5.

      Secondary outcomes: duration of the antibiotic treatment, mortality rate and duration in stay
      in intensive care ward and evolution of the SOFA score between D0, D3 and D5.

      Duration of patient enrollment is 30 days.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    65 patients were included after 2 years instead of 140
  </why_stopped>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rate of patients undergoing antibiotic treatment at D5.</measure>
    <time_frame>at D5</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>evolution of the SOFA score between D0, D3 and D5.</measure>
    <time_frame>D30</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Procalcitonin level</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>duration of the antibiotic treatment guided by procalcitonin level</description>
  </arm_group>
  <arm_group>
    <arm_group_label>physician's appreciation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>duration of the antibiotic treatment based on physician's appreciation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Procalcitonin level</intervention_name>
    <description>The duration of antibiotic treatment is based on PCT level:
&lt; 0.25 ng/ml: antibiotic should be stopped
0.25 &lt; PCT &lt;0.5: antibiotic prescription is not recommended
&gt; 0.5 ng/ml: antibiotic should be used</description>
    <arm_group_label>Procalcitonin level</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hospitalized in resuscitation ward

          -  severe sepsis symptomatology

          -  at least 2 SIRS criteria

          -  no infectious etiology detected

          -  at least one organ deficiency

        Exclusion Criteria:

          -  the presence of a pathogen agent or infectious centre clearly identified

          -  pregnancy

          -  burned

          -  patients with therapeutic limitation

          -  recent surgery

          -  secondary neutropenia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Djillali Annane, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Raymond Poincaré hospital Garches-France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ICU in J.Minjoz hospital</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICU in Avicenne hospital</name>
      <address>
        <city>Bobigny</city>
        <zip>93009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICU in Ambroise Paré hospital</name>
      <address>
        <city>Boulogne</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICU in Raymond Poincaré hospital</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICU in André Boulloche hospital</name>
      <address>
        <city>Montbeliard</city>
        <zip>25200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICU in Centre hospitalier général</name>
      <address>
        <city>Mulhouse Belfort</city>
        <zip>90000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICU in St Etienne hospital</name>
      <address>
        <city>St Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICU in Purpan hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICU in Rangueil hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2009</study_first_submitted>
  <study_first_submitted_qc>December 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2009</study_first_posted>
  <last_update_submitted>December 3, 2010</last_update_submitted>
  <last_update_submitted_qc>December 3, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2010</last_update_posted>
  <responsible_party>
    <name_title>Djillali Annane/ Professor</name_title>
    <organization>Coordinator and Principal Investigator</organization>
  </responsible_party>
  <keyword>safety</keyword>
  <keyword>Procalcitonin</keyword>
  <keyword>PCT</keyword>
  <keyword>SOFA</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Antibiotic</keyword>
  <keyword>Strategy</keyword>
  <keyword>SIRS</keyword>
  <keyword>severe sepsis without obvious infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Calcitonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

